Country websites

Managers' transactions

Our Investor Relations work focuses on delivering comprehensive, transparent and timely information to all capital market participants.
Our Investor Relations work focuses on delivering comprehensive, transparent and timely information to all capital market participants.

To comply with article 19 of the Regulation (EU) No 596/2014 (Market Abuse Regulation), members of our Management and Supervisory Board  as well as other persons discharching managerial responsibilities and all person closely associated with the aforementioned persons shall notify the Company of each transaction with shares of Fresenius Medical Care and additional related financial instruments conducted on their own account if the transaction volume reaches a total amount of EUR 20,000 within a single year.

Contact us for further information

+49 6172 609 2525

Related content